150 different types of the HPV virus are known. Most of them are harmless to humans. However, 14 increase the risk of developing cervical cancer. They are the so-called "high-risk types".

Especially for women over 30 years of age, the HPV test as a supplement to the conventional screening is very useful and important for early detection. All women should have thin-layer cytology performed once a year for reliable diagnosis. The combination of these examinations optimizes your preventive and thus your safety.

We will be happy to answer any further questions on the subject of screening and HPV.


Every year 300.000 women in Germany are infected with chlamydia. This infection is one of the most common causes of female infertility.

Chlamydia is a bacterium that is mainly transmitted during unprotected sexual intercourse. Chlamydia infection is one of the most common sexually transmitted diseases. Untreated Chlamydia infections can lead to inflammation of the uterus and fallopian tubes.

But don't panic: If detected early, the infection is usually easily treatable.



Cervical cancer is the second most common cancer-related cause of death in women aged 25-35 years after breast cancer. About 1700 women die every year in Germany as a result of cervical cancer. And yet cervical cancer is preventable: because the annual cancer screening examination by a gynaecologist can protect against the development of cervical cancer.

During the early detection examination, a cell smear is taken from the cervix during the gynaecological examination using a cotton swab or other instrument. The cells are removed from the surface of the cervix and remain attached to the removal instrument. The removed cells are placed on a microscope slide, prepared and stained in the laboratory and then examined under the microscope. This makes it possible to detect cell changes that indicate inflammation or degeneration.

Since the PAP test was developed about 50 years ago, the technique has not changed significantly. Under optimal conditions, this test offers a relatively high level of certainty with a success rate of up to 80%. It therefore still has a high significance. In practical routine, however, there are also problems and possible errors that limit its reliability.

A technical advancement of the conventional Pap test is the ThinPrep® Pap test. It has been developed to reduce the problems and errors associated with the conventional Pap test and represents the first decisive technical improvement in cytological testing.

In a large comparative study between the conventional Pap test and the ThinPrep® Pap Test, it was shown that the success rates could be increased by 72% for mild cell changes (dysplasia) and by 103% for severe cell changes compared to the conventional method. This greater reliability and significance also means greater safety for the women examined.

  • Reliable
  • Meaningful
  • Increased security
  • 72% higher success rate
  • 103% for severe cell changes

Without ThinPrep®

With ThinPrep®



discovering hands® uses the superior sense of touch of blind and visually impaired people to improve tactile diagnostics in the context of early detection of breast cancer. This innovative concept not only creates a higher degree of safety for the detection of breast changes, but also enables women to enjoy a pleasant examination situation with a maximum of attention and time. In a 9-month theoretical and practical training course, blind and visually impaired people are trained in qualified vocational training centers to become medical palpation assistants (MTU). Further information is available on the website